View ValuationChengdu Guibao Science & TechnologyLtd 향후 성장Future 기준 점검 1/6Chengdu Guibao Science & TechnologyLtd (는) 각각 연간 14.5% 및 14.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 14.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.2% 로 예상됩니다.핵심 정보14.5%이익 성장률14.38%EPS 성장률Chemicals 이익 성장30.5%매출 성장률14.1%향후 자기자본이익률11.25%애널리스트 커버리지Low마지막 업데이트21 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 21, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 21, 2026공시 • Mar 28Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026, at 14:00 China Standard Time. Location: No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan China공시 • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 28, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 28, 2026공시 • Jul 02Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025공시 • May 09Chengdu Guibao Science & Technology Co.,Ltd. Announces Director AppointmentsChengdu Guibao Science & Technology Co.,Ltd. at its EGM held on May 7, 2025, approved: Election and nomination of non-independent and independent directors: Zhao Kexing, non-independent director; Liu Qi, non-independent director; Wang Jiayu, non-independent director; Yi Yang, independent director.공시 • Apr 24Chengdu Guibao Science & Technology Co.,Ltd. Approves Cash Dividend for 2024Chengdu Guibao Science & Technology Co.,Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 3.00000000 per 10 shares (tax included) for 2024.공시 • Apr 01Chengdu Guibao Science & Technology Co.,Ltd. Announces Profit Distribution Proposal for the Year 2024Chengdu Guibao Science & Technology Co.,Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 3.000000 for the year 2024.공시 • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025공시 • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: 6F, No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan China공시 • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 29, 2025Reported Earnings • Oct 22Third quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.23 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.14 (down from CN¥0.23 in 3Q 2023). Revenue: CN¥974.1m (up 36% from 3Q 2023). Net income: CN¥56.7m (down 38% from 3Q 2023). Profit margin: 5.8% (down from 13% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 30%After last week's 30% share price gain to CN¥14.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 9.7% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.83 per share.공시 • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024Reported Earnings • Aug 24Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.20 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.16 (down from CN¥0.20 in 2Q 2023). Revenue: CN¥684.0m (up 3.2% from 2Q 2023). Net income: CN¥61.6m (down 20% from 2Q 2023). Profit margin: 9.0% (down from 12% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공시 • Jun 29Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024Declared Dividend • Apr 26Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2024 Payment date: 30th April 2024 Dividend yield will be 2.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (39% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 106% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Apr 22Now 30% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to CN¥13.06. The fair value is estimated to be CN¥18.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has grown by 6.5%. Revenue is forecast to grow by 81% in 2 years. Earnings are forecast to grow by 76% in the next 2 years.공시 • Mar 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024Reported Earnings • Mar 30Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)Full year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China.공시 • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Chengdu, Sichuan China공시 • Feb 22Chengdu Guibao Science & Technology to Buy Hot Melt Adhesive FirmChengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) said it plans to buy hot melt adhesive firm with estimated valuation of CNY 480 million ($66.72 million).Reported Earnings • Feb 03Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)Full year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.47, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.41 per share.공시 • Dec 29Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024Reported Earnings • Oct 20Third quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.23 (up from CN¥0.16 in 3Q 2022). Revenue: CN¥718.8m (up 13% from 3Q 2022). Net income: CN¥91.2m (up 45% from 3Q 2022). Profit margin: 13% (up from 9.9% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.공시 • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 19, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2023 results on Oct 19, 2023Reported Earnings • Aug 12Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.15 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.15 in 2Q 2022). Revenue: CN¥662.9m (down 6.9% from 2Q 2022). Net income: CN¥77.3m (up 28% from 2Q 2022). Profit margin: 12% (up from 8.4% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.공시 • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 12, 2023Reported Earnings • Mar 26Full year 2022 earnings released: EPS: CN¥0.64 (vs CN¥0.70 in FY 2021)Full year 2022 results: EPS: CN¥0.64 (down from CN¥0.70 in FY 2021). Revenue: CN¥2.69b (up 5.4% from FY 2021). Net income: CN¥250.3m (down 6.5% from FY 2021). Profit margin: 9.3% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China.Board Change • Mar 14High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. Independent Director Xianye Tang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.이익 및 매출 성장 예측XSEC:300019 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20285,954394246421112/31/20275,514349277410112/31/20265,112322-203-6813/31/20263,816254395491N/A12/31/20253,751279446578N/A9/30/20253,677308576697N/A6/30/20253,708290375486N/A3/31/20253,463268211372N/A12/31/20243,159238315484N/A9/30/20242,82625016230N/A6/30/20242,57028579324N/A3/31/20242,549300175401N/A12/31/20232,606315247436N/A9/30/20232,588308379533N/A6/30/20232,507280385513N/A3/31/20232,556263239353N/A12/31/20222,69425019127N/A9/30/20222,89327214115N/A6/30/20222,929277-6829N/A3/31/20222,867282-5338N/A1/1/20222,55626888176N/A9/30/20212,263228-685N/A6/30/20211,98822361143N/A3/31/20211,726219115196N/A12/31/20201,524201151222N/A9/30/20201,28818390141N/A6/30/20201,14515988127N/A3/31/20209931286890N/A12/31/20191,018132N/A82N/A9/30/2019961128N/A79N/A6/30/201991499N/A60N/A3/31/201990581N/A38N/A12/31/201887165N/A68N/A9/30/201881739N/A36N/A6/30/201878444N/A57N/A3/31/201875847N/A83N/A12/31/201772852N/A92N/A9/30/201772157N/A102N/A6/30/201770872N/A101N/A3/31/201766280N/A91N/A12/31/201665291N/A78N/A9/30/201662195N/A74N/A6/30/201661393N/A60N/A3/31/201661192N/A71N/A12/31/201560689N/A66N/A9/30/201559183N/A31N/A6/30/201558583N/A42N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 300019 의 연간 예상 수익 증가율(14.5%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 300019 의 연간 수익(14.5%)이 CN 시장(27.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 300019 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 300019 의 수익(연간 14.1%)이 CN 시장(연간 16.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 300019 의 수익(연간 14.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 300019의 자본 수익률은 3년 후 11.2%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/26 15:11종가2026/05/26 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Chengdu Guibao Science & Technology Co.,Ltd.는 3명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Wei MaoEverbright Securities Co. Ltd.Lin YangGuosen Securities Co., Ltd.Sen ZhaoHuatai Research
공시 • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 21, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 21, 2026
공시 • Mar 28Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026, at 14:00 China Standard Time. Location: No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan China
공시 • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 28, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 28, 2026
공시 • Jul 02Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025
공시 • May 09Chengdu Guibao Science & Technology Co.,Ltd. Announces Director AppointmentsChengdu Guibao Science & Technology Co.,Ltd. at its EGM held on May 7, 2025, approved: Election and nomination of non-independent and independent directors: Zhao Kexing, non-independent director; Liu Qi, non-independent director; Wang Jiayu, non-independent director; Yi Yang, independent director.
공시 • Apr 24Chengdu Guibao Science & Technology Co.,Ltd. Approves Cash Dividend for 2024Chengdu Guibao Science & Technology Co.,Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 3.00000000 per 10 shares (tax included) for 2024.
공시 • Apr 01Chengdu Guibao Science & Technology Co.,Ltd. Announces Profit Distribution Proposal for the Year 2024Chengdu Guibao Science & Technology Co.,Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 3.000000 for the year 2024.
공시 • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025
공시 • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: 6F, No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan China
공시 • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 29, 2025
Reported Earnings • Oct 22Third quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.23 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.14 (down from CN¥0.23 in 3Q 2023). Revenue: CN¥974.1m (up 36% from 3Q 2023). Net income: CN¥56.7m (down 38% from 3Q 2023). Profit margin: 5.8% (down from 13% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 30%After last week's 30% share price gain to CN¥14.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 9.7% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.83 per share.
공시 • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024
Reported Earnings • Aug 24Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.20 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.16 (down from CN¥0.20 in 2Q 2023). Revenue: CN¥684.0m (up 3.2% from 2Q 2023). Net income: CN¥61.6m (down 20% from 2Q 2023). Profit margin: 9.0% (down from 12% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공시 • Jun 29Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024
Declared Dividend • Apr 26Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2024 Payment date: 30th April 2024 Dividend yield will be 2.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (39% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 106% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Apr 22Now 30% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to CN¥13.06. The fair value is estimated to be CN¥18.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has grown by 6.5%. Revenue is forecast to grow by 81% in 2 years. Earnings are forecast to grow by 76% in the next 2 years.
공시 • Mar 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024
Reported Earnings • Mar 30Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)Full year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China.
공시 • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Chengdu, Sichuan China
공시 • Feb 22Chengdu Guibao Science & Technology to Buy Hot Melt Adhesive FirmChengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) said it plans to buy hot melt adhesive firm with estimated valuation of CNY 480 million ($66.72 million).
Reported Earnings • Feb 03Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)Full year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.47, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.41 per share.
공시 • Dec 29Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024
Reported Earnings • Oct 20Third quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.23 (up from CN¥0.16 in 3Q 2022). Revenue: CN¥718.8m (up 13% from 3Q 2022). Net income: CN¥91.2m (up 45% from 3Q 2022). Profit margin: 13% (up from 9.9% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
공시 • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 19, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2023 results on Oct 19, 2023
Reported Earnings • Aug 12Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.15 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.15 in 2Q 2022). Revenue: CN¥662.9m (down 6.9% from 2Q 2022). Net income: CN¥77.3m (up 28% from 2Q 2022). Profit margin: 12% (up from 8.4% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
공시 • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 12, 2023
Reported Earnings • Mar 26Full year 2022 earnings released: EPS: CN¥0.64 (vs CN¥0.70 in FY 2021)Full year 2022 results: EPS: CN¥0.64 (down from CN¥0.70 in FY 2021). Revenue: CN¥2.69b (up 5.4% from FY 2021). Net income: CN¥250.3m (down 6.5% from FY 2021). Profit margin: 9.3% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China.
Board Change • Mar 14High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. Independent Director Xianye Tang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.